UK markets close in 2 hours 17 minutes

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
30.21+0.68 (+2.30%)
At close: 04:00PM EDT
29.75 -0.46 (-1.52%)
After hours: 04:05PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
26,823
26,823
14,240
0
0
Cost of revenue
2,881
2,881
1,704
0
2,805
Gross profit
23,942
23,942
12,536
0
200,391
Operating expenses
Research development
295,526
295,526
279,910
256,973
220,811
Selling general and administrative
119,903
119,903
121,673
121,445
115,105
Total operating expenses
415,429
415,429
401,583
378,418
335,916
Operating income or loss
-391,487
-391,487
-389,047
-378,418
-335,916
Interest expense
-
-
-
-
17,832
Total other income/expenses net
6,055
6,055
144,453
21,072
-
Income before tax
-352,088
-352,088
-231,801
-356,510
-329,305
Income from continuing operations
-352,088
-352,088
-231,801
-356,510
-329,305
Net income
-352,088
-352,088
-231,801
1,604,715
-327,370
Net income available to common shareholders
-352,088
-352,088
-231,801
1,604,715
-327,370
Basic EPS
-3.94
-
-4.23
26.55
-4.74
Diluted EPS
-3.94
-
-4.23
26.55
-4.74
Basic average shares
55,409
-
54,789
60,447
68,998
Diluted average shares
55,409
-
54,789
60,447
68,998